A blood clot blocks the blood supply to certain parts of the body and can cause severe damage in the long run. However, it can be treated using different clot management devices, such as embolectomy balloon catheters, neurovascular embolectomy devices, catheter-directed thrombolysis (CDT), percutaneous thrombectomy devices and inferior vena cava filters (IVCF). These devices further help in preventing ischemic strokes, severe leg pain and heart attacks. The global clot management devices market grew at a CAGR of around 4.5% during 2014-2019. Looking forward, the market is expected to continue its moderate growth during the next five years., according to a new report by IMARC Group.
Request for a free sample copy of this report: https://www.imarcgroup.com/clot-management-devices-market/requestsample
Market Trends
The rising prevalence of cardiovascular diseases (CVDs), along with the growing number of smokers, is increasing the risk of blood clots among individuals. This represents one of the key factors bolstering the clot management devices market growth. Additionally, the escalating demand for minimally invasive (MI) surgeries over open surgeries, is further impelling the market growth. Other than this, some of the leading players in the industry are focusing on introducing technological advancements, which are expected to drive the market in the upcoming years. For instance, Penumbra, Inc., a US-based healthcare company, launched Reperfusion Catheters ACE68, which is a large-bore aspiration catheter designed to navigate tortuous vessels to facilitate extraction of clot quickly.
Competitive Landscape
The report has also examined the competitive landscape of global clot management market.
- AngioDynamics Inc.
- Argon Medical Devices Inc.
- Boston Scientific Corporation
- DePuy Synthes Inc.
- Edwards Lifesciences Corporation
- iVascular S.L.U.
- Lemaitre Vascular Inc.
- Medtronic Inc.
- Straub Medical AG
- Stryker Corporation
- Teleflex Incorporated
- Vascular Solutions
Key Segments of the Report:
Breakup by Product Type:
- Neurovascular Embolectomy Devices
- Embolectomy Balloon Catheters
- Percutaneous Thrombectomy Devices
- Mechanical Thrombectomy
- Aspiration Thrombectomy
- Percutaneous Mechanical Thrombectomy (PMT)
- Catheter-Directed Thrombolysis Devices
- Inferior Vena Cava Filters
- Permanent
- Retrievable
Breakup by End-User:
- Hospitals
- Diagnostic Centers and Specialty Clinics
Explore full report with table of contents: https://www.imarcgroup.com/clot-management-devices-market
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Browse Related Report:
https://www.imarcgroup.com/fusion-splicer-market
https://www.imarcgroup.com/hydraulic-cylinder-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
